Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daclizumab in chronic persistent asthma
NCT00028288Phase 2Completed
- Sponsor
- Facet Biotech Corporation
- Start
- Sep 2001
- Primary completion
- Dec 2003
- Countries
- 1
01
Overview
A Phase 2 trial of daclizumab in asthma, sponsored by Facet Biotech Corporation. Started Sep 2001; status: completed.
02
Drugs
daclizumab
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00028288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00028288.